Biblio

Found 265 results
2021
Dolbois A., Bedi R.K, Bochenkova E., Müller A., Moroz-Omori E.V, Huang D., Caflisch A..  2021.  1,4,9-Triazaspiro[5.5]undecan-2-one derivatives as potent and selective METTL3 inhibitors. Journal of Medicinal Chemistry. 64(17):12738-12760.
Li Y., Bedi R.K, Wiedmer L., Sun X., Huang D., Caflisch A..  2021.  Atomistic and thermodynamic analysis of N6-methyladenosine (mA) recognition by the reader domain of YTHDC1. Journal of Chemical Theory and Computation. 17(2):1240-1249.
Pohl M.O, Busnadiego I., Marrafino F., Wiedmer L., Hunziker A., Fernbach S., Glas I., Moroz-Omori E.V, Hale B.G, Caflisch A. et al..  2021.  Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir. Journal of General Virology. 102(7)
Cappelletti V., Hauser T., Piazza I., Pepelnjak M., Malinovska L., Fuhrer T., Li Y., Dörig C., Boersema P, Gillet L. et al..  2021.  Dynamic 3D proteomes reveal protein functional alterations at high resolution in situ. Cell. 184(2):545-559.e22.
Mallona I., Ilie I.M, Karemaker I.D, Butz S., Manzo M., Caflisch A., Baubec T..  2021.  Flanking sequence preference modulates de novo DNA methylation in the mouse genome. Nucleic Acids Research. 49(1):145–157.
Dalle Vedove A., Cazzanelli G., Corsi J., Sedykh M., D'Agostino V.G, Caflisch A., Lolli G..  2021.  Identification of a BAZ2A bromodomain hit compound by fragment joining. ACS Bio & Med Chem Au.
Moroz-Omori E.V, Huang D., Bedi R.K, Cheriyamkunnel S.J, Bochenkova E., Dolbois A., Rzeczkowski M.D, Li Y., Wiedmer L., Caflisch A..  2021.  METTL3 inhibitors for epitranscriptomic modulation of cellular processes. ChemMedChem.
Milardi D., Gazit E., Radford S.E, Xu Y., Gallardo R.U, Caflisch A., Westermark G.T, Westermark P., La Rosa C., Ramamoorthy A..  2021.  Proteostasis of islet amyloid polypeptide: a molecular perspective of risk factors and protective strategies for type II diabetes. Chemical Reviews. 121(3):1845-1893.
2020
Marchand J.R., Knehans T., Caflisch A., Vitalis A..  2020.  An ABSINTH-based protocol for predicting binding affinities between proteins and small molecules.. Journal of Chemical Information and Modeling. 60(10):5188-5202.
Goossens K., Wroblowski B., Langini C., Van Vlijmen H., Caflisch A., De Winter H..  2020.  Assessment of the fragment docking program SEED. Journal of Chemical Information and Modeling. 60(10):4881–4893.
Dolbois A., Batiste L., Wiedmer L., Dong J., Brütsch M., Huang D., Deerain N., Spiliotopoulos D., Cheng-Sánchez I., Laul E. et al..  2020.  Hitting a moving target: simulation and crystallography study of ATAD2 bromodomain blockers. ACS Medicinal Chemistry Letters. 11(8):1573-1580.
Caflisch A..  2020.  Kinetic control of amyloidogenesis calls for unconventional drugs to fight Alzheimer's disease. ACS Chemical Neuroscience. 11(2):103-104.
Cocina F., Vitalis A., Caflisch A..  2020.  SAPPHIRE-based clustering. Journal of Chemical Theory and Computation. 16(10):6383–6396.
Bedi R.K, Huang D., Wiedmer L., Li Y., Dolbois A., Wojdyla J.A, Sharpe M.E, Caflisch A., Śledź P..  2020.  Selectively disrupting m6A-dependent protein-RNA interactions with fragments. ACS Chemical Biology. 15(3):618-625.
Bedi R.K, Huang D., Eberle S.A, Wiedmer L., Śledź P., Caflisch A..  2020.  Small-molecule inhibitors of METTL3, the major human epitranscriptomic writer. ChemMedChem. 15(9):744-748.
Li Y., Bedi R.K, Moroz-Omori E.V, Caflisch A..  2020.  Structural and dynamic insights into redundant function of YTHDF proteins. Journal of Chemical Information and Modeling. 60(12):5932-5935.
Pretze M., Neuber C., Kinski E., Belter B., Köckerling M., Caflisch A., Steinbach J., Pietzsch J., Mamat C..  2020.  Synthesis, radiolabelling and initial biological characterisation of F-labelled xanthine derivatives for PET imaging of Eph receptors. Organic & Biomolecular Chemistry. 18(16):3104-3116.
Unzue A., Jessen-Trefzer C., Spiliotopoulos D., Gaudio E., Tarantelli C., Dong J., Zhao H., Pachmayr J., Zahler S., Bernasconi E. et al..  2020.  Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors. RSC Medicinal Chemistry. 11(8):1573-1580.

Pages